Rapid Micro Biosystems, Inc. (NASDAQ:RPID) CEO Robert G. Jr. Spignesi Sells 11,881 Shares

Rapid Micro Biosystems, Inc. (NASDAQ:RPID - Get Free Report) CEO Robert G. Jr. Spignesi sold 11,881 shares of the business's stock in a transaction that occurred on Monday, July 14th. The stock was sold at an average price of $3.32, for a total transaction of $39,444.92. Following the transaction, the chief executive officer owned 970,550 shares of the company's stock, valued at $3,222,226. This trade represents a 1.21% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.

Rapid Micro Biosystems Stock Down 0.3%

NASDAQ RPID traded down $0.01 on Friday, hitting $3.44. 7,139 shares of the stock were exchanged, compared to its average volume of 196,826. Rapid Micro Biosystems, Inc. has a fifty-two week low of $0.64 and a fifty-two week high of $4.04. The company has a market cap of $150.78 million, a PE ratio of -3.34 and a beta of 1.32. The company has a 50-day moving average price of $3.38 and a 200-day moving average price of $2.64.

Rapid Micro Biosystems (NASDAQ:RPID - Get Free Report) last issued its earnings results on Friday, May 9th. The company reported ($0.26) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.27) by $0.01. Rapid Micro Biosystems had a negative net margin of 151.22% and a negative return on equity of 56.07%. The business had revenue of $7.21 million during the quarter, compared to analysts' expectations of $6.63 million. As a group, equities research analysts predict that Rapid Micro Biosystems, Inc. will post -1.1 EPS for the current fiscal year.

Institutional Trading of Rapid Micro Biosystems

Hedge funds and other institutional investors have recently made changes to their positions in the company. Parkman Healthcare Partners LLC purchased a new position in shares of Rapid Micro Biosystems in the 1st quarter valued at about $1,942,000. ABG WTT Global Life Science Capital Partners GP Ltd increased its holdings in Rapid Micro Biosystems by 78.0% during the 1st quarter. ABG WTT Global Life Science Capital Partners GP Ltd now owns 1,848,296 shares of the company's stock valued at $4,880,000 after acquiring an additional 810,000 shares in the last quarter. OMERS ADMINISTRATION Corp purchased a new position in Rapid Micro Biosystems during the 1st quarter valued at about $289,000. American Century Companies Inc. purchased a new position in Rapid Micro Biosystems during the 1st quarter valued at about $31,000. Finally, Informed Momentum Co LLC acquired a new stake in shares of Rapid Micro Biosystems during the 1st quarter worth about $467,000. Hedge funds and other institutional investors own 52.60% of the company's stock.

Rapid Micro Biosystems Company Profile

Rapid Micro Biosystems, Inc, a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, medical devices, and personal care products in the United States, Germany, Switzerland, Japan, and internationally. The company offers Growth Direct platform, which includes Growth Direct system, proprietary consumables, lab information management system connection software, and customer support and validation services.